Raymond James Financial
GILD icon

Raymond James Financial’s Gilead Sciences GILD Stock Holding History

Raymond James Financial’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308M Sell
2,436,019
-125,633
-5% -$16.6M 0.08% 206
2026
Q1 		$355M Sell
2,561,652
-173,265
-6% -$24.3M 0.11% 159
2025
Q4 		$336M Buy
2,734,917
+919,106
+51% +$112M 0.1% 164
2025
Q3 		$202M Buy
1,815,811
+51,188
+3% +$5.82M 0.06% 270
2025
Q2 		$196M Sell
1,764,623
-271,484
-13% -$28.9M 0.07% 262
2025
Q1 		$228M Sell
2,036,107
-208,563
-9% -$21.5M 0.09% 216
2024
Q4 		$207M Buy
+2,244,670
New +$202M 0.08% 226

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial's GILD Position: Q2 2026 in Review

Raymond James Financial reduced its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, selling an estimated $16.6M and leaving 2,436,019 shares worth $308M. The position accounts for 0.08% of the portfolio, ranked #206.

Raymond James Financial first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $355M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Raymond James Financial held 2,436,019 shares of Gilead Sciences worth $308M as of Q2 2026.
  • Raymond James Financial sold 125,633 Gilead Sciences shares in Q2 2026, an estimated $16.6M.
  • Gilead Sciences made up 0.08% of Raymond James Financial's portfolio in Q2 2026, its #206 holding.
  • Raymond James Financial first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Gilead Sciences position peaked at $355M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.